GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Valuation Rank

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Valuation Rank


View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

China Resources Double-Crane Pharmaceutical Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Double-Crane Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Valuation Rank
Comparable Companies
SZSE:000623 SHSE:688192 SZSE:300142 SHSE:600380 SZSE:000739 SZSE:002755 SHSE:600329 SZSE:300601 SZSE:000766 SZSE:300558 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102
Website
http://www.dcpc.com
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.
Executives
Yu Shun Ting Director
Han Shuo senior management
Liu Zi Qin senior management
Fan Yan Xi senior management
Lu Wen Chao Directors, senior managers
Man Chao senior management
Ni Jun senior management
Feng Yi Director
Zheng Ze Ping Supervisors
Li Ying senior management